Syngene reports FY26 revenue of Rs 3,739 Cr, up 3%; Q4 revenue at Rs 1,037 Cr
Steady growth led by biologics and CRDMO business, EBITDA margin at 25% with continued investments in ADCs, peptides, and digital capabilities
Steady growth led by biologics and CRDMO business, EBITDA margin at 25% with continued investments in ADCs, peptides, and digital capabilities
The aim is to simplify and strengthen long-term control of airway disease through triple therapy in one device
Avio Smart Market Stack Limited and Huwel Lifesciences unveil portable, cost-efficient molecular testing platform
Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living
nSEPIA aims to bring structure to an area long dominated by subjectivity
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
Multidisciplinary team expansion brings integrated medical, surgical, and radiation oncology services under one roof
AI-powered platform uses real-time emotion scanning and personalised interventions to make emotional wellness measurable and actionable
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
Subscribe To Our Newsletter & Stay Updated